Croissy-Beaubourg, April 22, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER) specializes in in vitro diagnostics and theranostics. Strategic positioning and decisions on Covid-19 serological testsFollowing the approval of Theradiag’s Board of Directors, at a…
Croissy-Beaubourg, April 21, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, hereby confirms the holding of its Annual General Meeting on May 14, 2020 at…
2019 revenue up 10.3% for theranostics and up 6.4% for IVD Continued improvement in operating income and net income before non-recurring items Positive net income partly driven by non-recurring instrumentation sales. Profits reinvested in development…